Evidence map›Paper›PMID 42293774›Full record

ArticleGastro hep advances2026

Disseminated Tuberculosis With Placental Involvement in a Crohn's Disease Patient Treated With Combination Therapy.

Natália de Castro Borges, Hélio Paulo de Matos Neto, Lawani Rigopoulos, Maria Paula Ribeiro Dantas Bezerra, Maria Carolina Dias Rego, Luísa Leite Barros

Abstract readCase Reports
In one paragraph

Article in Gastro hep advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Natália de Castro BorgesDepartment of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.
Hélio Paulo de Matos NetoDepartment of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.
Lawani RigopoulosDepartment of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.
Maria Paula Ribeiro Dantas BezerraDepartment of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.
Maria Carolina Dias RegoDepartment of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.
Luísa Leite BarrosDepartment of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the current therapeutic landscape of inflammatory bowel disease, safety considerations regarding immunosuppressive agents are essential. Combination therapy with antitumor necrosis factor agents and thiopurines increases the risk of opportunistic infections, including tuberculosis. We report the case of a 39-year-old pregnant woman with ileal Crohn's disease who developed severe, life-threatening disseminated tuberculosis during treatment with infliximab and azathioprine. The case highlights the possibility of involvement of atypical sites, such as the placenta. In endemic areas, a high index of suspicion is required for uncommon manifestations of the disease.

Indexed as

Anti-TNFCrohn’s DiseasePregnancyTuberculosis

Identifiers

PMID42293774
PMCPMC13262145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.